Connect with us

Investment

Chemistree Details Immunoflex Investment – Canada NewsWire

Published

on


Cannabinoid-Linked, Immunology and Virology focused Biotech Venture

VANCOUVER, BC, June 18, 2020 /CNW/ – Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), further to its announcement on June 15, 2020, the Company is pleased to introduce ImmunoFlex Therapeutics Inc. (“ImmunoFlex”) and provide a complete description of the investment per the Binding Letter of Intent.

ImmunoFlex is a team unified around a common goal of working with the immune system to prevent and combat disease. The first products are designed to improve the way the world prevents and treats viral infection. ImmunoFlex works to find solutions for people who want to enhance the preparedness of their immune function in defence and combat viral infection; preventing occurrences, and decreasing the severity of viral infections. By learning from the immune system, ImmunoFlex develops products that leverage existing compounds previously unknown ability to provide immune preparedness and resilience.

For the past three months, Chemistree has been regularly solicited with requests for funding by ventures proposing treatments or products related to the current pandemic, most of which lacked the team and development that ImmunoFlex displays. Chemistree’s management immediately recognized that the ImmunoFlex team had been working on immunological and virological therapeutics well before the outbreak of the global pandemic. It is this level of high-quality scientific research and logical product development in the field of immune system response that makes ImmunoFlex an important and timely investment.

Chemistree President Karl Kottmeier commented, “We are thrilled to be the primary seed investors into ImmunoFlex. The timeliness of the products under development, driven by the tremendous collective experience and successes of the ImmunoFlex management team makes this truly a compelling investment for Chemistree. It is rare for a small company like Chemistree to get a chance to provide funding to a start up like ImmunoFlex. The track record of Dr. Vernon Oi alone as one of Stanford University’s most prolific patent filers and royalty generators would normally place this out of reach for Chemistree. Fortunately, our positioning as a cannabis-focused investment company and ideal timing made this possible. I encourage shareholders and interested investors to go to www.immunoflex.com to get a full understanding of this exciting new opportunity.”

ImmunoFlex CEO Chris Wagner stated, “ImmunoFlex works with the immune system to prevent and combat disease. We started with a shared interest in understanding the immune system and how different compounds have the potential to strengthen, support, and enhance our bodies natural surveillance system. Our research led us to form ImmunoFlex, where we develop and commercialize novel patented products that counteract weakened immune systems and diminished immune repertoire caused by a lifetime of battling viruses and disease. We are using genomics and other modern scientific tools to repurpose existing natural health products and studying their ability to enhance the human immune system and its capacity to prevent and combat viral infections. Our first product launch, targeted for late 2020, is pharmaceutical grade and designed to improve adaptive immunity biomarkers. We believe this product will become especially important for researchers, clinical users, and people interested in enhancing their immune system’s ability to respond to new threats. Chemistree’s support of ImmunoFlex is a strong signal from professional investors who believe we can improve the health of a large group of people.”

Chemistree’s investment in ImmunoFlex is subject to confirmatory due diligence and the completion of a definitive investment agreement. The investment includes an initial common share purchase of $500,000, together with Chemistree being granted a gross sales royalty on ImmunoFlex’s North American sales; a further $500,000 second tranche common share purchase is conditional on certain performance by ImmunoFlex. In addition, Chemistree is entitled to anti-dilution pre-emptive rights and to appoint one person to ImmunoFlex’s board of directors.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets and to invest in other cannabis-related opportunities, leveraging management’s decades of expertise in the cannabis industry and corporate finance.

For more information, visit www.Chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws
The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defence to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Prospectus, the Company’s annual information form and other documents incorporated by reference therein and in the Company’s Form 2A listing statement filed with the CSE and available under the Company’s profile on SEDAR at www.sedar.com.

“Karl Kottmeier”
President 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Information set forth in this news release includes forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “budget”, “scheduled” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein, without limitation, statements with respect to the investment and grant of a royalty interest, and entry into of definitive agreements.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

SOURCE Chemistree Technology Inc.

For further information: Chemistree Technology Inc., Karl Kottmeier, President, Phone: 604-678-8941, Email: [email protected]; For investor relations please contact: Contact Financial Corp., Kirk Gamley, Phone: 604-689-7422, Email: [email protected]

Related Links

http://chemistree.ca/

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Beginner investors should follow this timeless advice from Warren Buffett – Financial Post

Published

on


This article was created by StackCommerce. While Postmedia may collect a commission on sales through the links on this page, we are not being paid by the brands mentioned.

Taking that leap into investing your money isn’t easy. If you’re not careful, you can wind up losing money. (You probably will at some point anyway, to be fair.) Luckily for all those curious to dive into the investment world, there are plenty of experts out there who you can learn from.

For example, American investor and billionaire Warren Buffet has some timeless tips that can steer you in the right direction.

Of course, if you want to really dig in and grow your investing know-how, The Complete Finance Training & Investing Bundle is another great resource you can use to take your understanding further. Below, we’ve highlighted some timeless advice from Buffett as well as how this training bundle can help you become a better investor. Read on for details:

When you buy a stock, plan to hold onto it forever

Buying stocks isn’t like purchasing the latest fashion trend. You want to be sure you’re buying something you want 10 years down the line. “Our favourite holding period is forever,” Buffet once said. That’s because the more you buy and trade stocks, the higher your tax returns. Plus, building wealth takes time.

The course “You Won’t Get Rich in the Stock Market” can help instill this understanding. It offers knowledge on a long-term planning strategy for financial independence, as well as insight on the amount of wealth necessary for a secure future. It’s a good basics course that will further bring home why stocks are something to hold onto.

There’s no easy answer to investing

Look, investing isn’t exactly complicated, but that doesn’t mean it’s simple, either. You don’t have to be a master of economics to be able to effectively invest your money, but you can’t turn to a set of rules to answer every question related to an investment. It’s something that takes time and thought to do right. “You don’t need to be a rocket scientist,” Buffet said. “Investing is not a game where the guy with the 160 IQ beats the guy with the 130 IQ.”

The bundle’s “The Complete Financial Analyst Training & Investing Course” offers 22 hours of TEDxTalk speaker and venture capitalist Chris Haroun’s expertise. Here, you can learn about risk management and how to value companies so you make informed decisions when buying stocks.

Be sensible

That means don’t take too many risks, make emotional decisions, or time the market. Low-cost index funds are a sensible choice for a beginner investor. Buffet is big on these! They don’t carry the fees that other investment funds do. It’s not only a safe strategy; it’s one that works. “Investing 102: Stock Markets & Index Funds – Learn to Invest” teaches you how to build a diversified portfolio and a key rule: Never invest what you’re not willing to lose.

Understand price versus value

Stock prices aren’t always the best marker to determine the value of a company. For instance, stock prices may drop during financial crises—but that doesn’t mean those companies aren’t worth investing in. After all, we’re thinking long-term here, right? These are often the best moments to buy quality stock. It’s cheaper. “Price is what you pay,” Buffet said. “Value is what you get.”

“Investing 102: Stock Markets & Index Funds – Learn to Invest” is a great course to really dig into the difference between value and price. That’s why The Complete Finance Training & Investing Bundle is a worthy investment for only $34.99 USD today. The course can be your first step toward securing financial freedom.

Prices subject to change.

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Africa’s Biggest Investment Takes Shape Under Islamist Threat – Yahoo Canada Finance

Published

on


(Bloomberg) — Dozens of soldiers clutching AK-47s and grenade launchers watch over roaring bulldozers on the white sand beach that meets a tropical turquoise sea. They’re guarding Africa’s biggest investment: a $23 billion project to export Mozambique’s natural gas from an area increasingly besieged by an Islamist insurgency.

Companies led by Total SA will pump the gas from wells about 40 kilometers (25 miles) offshore, cool it to temperatures below minus 260 degrees Fahrenheit so that it turns to liquid, then ship it to electricity plants from France to China. The consortium is about to finalize almost $16 billion in project financing — another record for the continent.

“The work is immense,” said Ronan Bescond, the 44-year-old French chemical engineer who Total chose to lead the project after a career of nearly two decades at the company. “The first cargo of LNG must be in 2024. And we are on the right track,” he said to a handful of reporters in a prefabricated room at the site 32 kilometers south of the Rovuma River that marks the border with Tanzania.

The obstacles facing a project that’s expected to transform the impoverished southeast African nation are huge.

To achieve the target of first production for an undertaking worth billions of dollars more than Mozambique’s entire economy, developers need to move thousands of tons of equipment through territory thick with Islamic State-aligned insurgents. At one stage, a Covid-19 outbreak saw the Total site accounting for three in four of the country’s confirmed infections. All this as natural-gas prices plunged to near 25-year lows.

Militants who first pledged allegiance to IS in 2018 have carried out increasingly brazen attacks this year.

Deadly Raid

Last week, they raided Mocimboa da Praia for a third time, and occupied the town for as long as three days. It’s a crucial supply hub just 60 kilometers south of the project site and the closest port.

As many as nine workers for Total subcontractors Fenix Construction Services Lda died in the attack, Jasmine Opperman, an African analyst at Wisconsin-based Armed Conflict Location & Event Data Project, said in a Twitter post. The company didn’t answer seven calls and two emails seeking comment.

Before the gas discoveries and insurgency, the remote coastline was more famous for luxury tropical island resorts. Last month, one of the nearby hotels offered a discount price of $19,820 a night to hire out an island as a refuge from the coronavirus.

The private military company that Mozambique hired in April to provide air support to government troops in the form of helicopters fitted with machine guns has struggled to quell the violence. Lionel Dyck, the founder of Dyck Advisory Group, the firm the government employed, declined to comment when contacted by mobile phone.

IS Warning

Governments including South Africa, the U.S. and Portugal have indicated willingness to help fight the insurgency.

“The insurgency is a challenge but we’re happy that our defense and security forces have been playing their role,” Max Tonela, Mozambique’s energy and natural resources minister, told reporters during the June 19 site visit. “We all as Mozambicans must fight against this evil that comes from external attacks.”

About 1,300 people have died in the violence, with a further 220,000 displaced since the first attack three years ago, which also took place at Mocimboa da Praia.

For the second time, IS referred directly to the projects in a weekly newsletter this month. The group said that it would be “delusional” to think that the government could protect the investments, and warned other countries against getting involved.

The marginalization of young men in a region that’s predominantly Muslim and 1,900 kilometers away from the capital, Maputo, has helped lead to radicalization that’s fueled the insurgency, according to researchers including Saide Habibe at the Maputo-based Institute of Social and Economic Studies who have studied the origins of the fighters.

Total’s project will hire 14,000 people at peak construction, of which at least 5,000 will be Mozambican and many from the region, Bescond said at the briefing, wearing a surgical mask, as all visitors to the site must do to prevent another outbreak of the coronavirus.

The financial rewards are worth the cost to the government of the soldiers patrolling the vast compound and snipers on its perimeter fence — Total’s estimate is $50 billion in direct and indirect revenue over 25 years for the $15 billion economy.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="For more articles like this, please visit us at bloomberg.com” data-reactid=”31″>For more articles like this, please visit us at bloomberg.com

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Subscribe now to stay ahead with the most trusted business news source.” data-reactid=”32″>Subscribe now to stay ahead with the most trusted business news source.

©2020 Bloomberg L.P.

Let’s block ads! (Why?)



Source link

Continue Reading

Investment

Indonesia says trade, investment deal with Australia takes effect – TheChronicleHerald.ca

Published

on


JAKARTA (Reuters) – An Indonesia-Australia deal that eliminates most trade tariffs between the two nations and aims to open up investment, took effect on Sunday, Indonesia’s Trade Ministry said.

The Indonesia-Australia Comprehensive Economic Partnership Agreement (IA-CEPA), signed last year and ratified by the Indonesia’s parliament in February, aims to boost bilateral trade that was worth $7.8 billion in 2019.

“COVID-19 has resulted in economic slowdown in nearly all countries,” Trade Minister Agus Suparmanto said in a statement. “IA-CEPA momentum can be used to maintaining Indonesian trade and improve competitiveness.”

In a signing ceremony last year, the two countries said the pact would eliminate all Australian tariffs on imports from Indonesia, while 94% of Indonesian tariffs would be gradually removed.

Australia aims to boost exports including wheat, iron ore and dairy, while Indonesia hopes to increase automotive exports, textile and electronics. The deal opens up investment, including for Australian universities in Indonesia.

The ministry said in the statement it has issued three regulations to allow for implementation of the deal.

(Reporting by Fransiska Nangoy; Editing by William Mallard)

Let’s block ads! (Why?)



Source link

Continue Reading

Trending